AI workflow software for pharma quantitative primary market research
From study brief to PowerPoint report faster and easier.
NquiRx gives pharma insights teams one place to build, field, manage, and report quantitative research. Nquirer, its AI agent, works across the study to create drafts, prepare revisions and fieldwork follow-ups, and produce analysis outputs—while your team controls approvals and final decisions.
From brief to report
See the full study journey.
From study need through PowerPoint and Excel outputs, NquiRx keeps context and decisions connected. Give Nquirer a goal and it uses that live study record to prepare work across stages, pausing at the human decisions and approvals you configure.
Illustrative study workflow
One example study, with Nquirer working across connected stages.Stage 1 Study setup Brief ready
Study setup
Evaluate blinded oncology HCP concept preference.
US and Germany HCPs, oncology focus.
Stimulus attached, draft screener notes captured.
Launch-ready draft needed this week.
Eligibility, specialty, market, and concept-exposure checks prepared for review.
Profile preference, rationale, and open-end probes organized into a first draft.
Assumptions and open clarifications surfaced before stakeholder review.
Creating review-ready draft...
Stage 2 Questionnaire review Ready
Questionnaire review
Oncology HCP concept test
Use blinded product profile wording, keep the attribute order consistent, and apply the update across the master draft and Germany market version.
Preparing the revision...
Stage 3 Fieldwork management In field
Fieldwork management
Feasibility questions need an owner-ready follow-up before recruitment can move cleanly.
Can you confirm feasible incidence by market, target completes by Friday, and any exclusions needed for the blinded profile review?
Preparing the owner-ready vendor follow-up...
Stage 4 Analysis and reporting Ready for analysis
Analysis and reporting
Comments cluster around access, dosing simplicity, and confidence in the safety profile.
Access and affordability language appears in 9 of 18 comments.
Dosing simplicity is the strongest positive driver.
2 potential AE/PC mentions flagged for human review.
Preparing analysis outputs...
What changes
Faster, expert-led market research.
NquiRx keeps the study record, approvals, programming, fieldwork, and outputs connected. AI takes care of routine work and handoffs while researchers retain methodological judgment, approvals, and final interpretation.
Without NquiRx
- Briefs, comments, and vendor instructions move between separate files and threads.
- Questionnaire programming and launch require repeated handoffs and re-briefing.
- Fieldwork updates, exports, and reporting begin outside one shared study record.
With NquiRx
- Structured study context carries forward into a fully programmed survey.
- Review history, hosted links, and vendor updates stay attached to the study.
- PowerPoint reports and Excel outputs begin from the connected study record.
Team fit
Built for the teams behind pharma quantitative primary market research.
Whether you own the study, deliver it, or make fieldwork happen, NquiRx gives each team clearer workflow context around the work they already lead.
Panel and fieldwork firms
Panel and fieldwork firms
Add a higher-value study workflow capability around the respondent access and fieldwork execution your clients already rely on.
- Package panel recruitment with clearer questionnaire review, launch, and reporting context.
- Give clients a smoother path from approved materials to fieldwork status.
- Offer a stronger service layer without rebuilding your delivery model.
Pharma MR consultancies
Pharma MR consultancies
Consulting teams can accelerate the current study process, reduce manual coordination, and protect expert review time.
- Keep the brief, screener, questionnaire, and reviewer decisions connected.
- Spend less time translating comments, vendor instructions, and field updates.
- Preserve methodology ownership while lowering delivery cost and churn.
Pharma commercial and insights teams.
Pharma commercial and insights teams.
Bring the work around each quantitative study into a clearer review and delivery flow from study need through reporting.
- Give stakeholders a clearer way to review and approve study materials.
- Reduce the spreadsheet and email load around launch readiness.
- Give analysts a cleaner starting point, with study context and outputs carried forward together.
Built for the standards of pharma market research.
Approval gates, configurable respondent-facing legal and compliance language, reporting routes, and a study history keep participant protections, review, and coordination clear across insights, legal, privacy, and fieldwork partners.
Founder-led demo
Clarify that the profile is blinded and keep the attribute order consistent across markets.